The largest database of trusted experimental protocols

Mission shrna custom lentiviral particles

Manufactured by Merck Group

MISSION® shRNA Custom Lentiviral Particles are lentiviral particles designed for the delivery of short hairpin RNA (shRNA) into target cells. The particles are produced using a lentiviral vector system and can be customized with specific shRNA sequences to silence the expression of target genes.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using mission shrna custom lentiviral particles

1

Generation of Knockout THP-1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To generate knockout cells, we purchased MISSION® shRNA Custom Lentiviral Particles from Millipore Sigma, three shRNA template oligonucleotides targeting each of mRNA sequences. The shRNA templates were designed with the puromycin selection marker for positively selecting for cells with shRNA. Briefly summarizing transduction procedure, 2 x 104 THP-1 cells were seeded in a 96 well plate with 105 μl cell culture medium containing 8 μg/ml hexadimethrine bromide and 15 μl lentiviral particles. The supernatant was replaced with the fresh cell culture medium on the next day. Successfully transduced cells were selected with 5 μg/ml puromycin beginning day 5 post-transduction. Empty vectors, MISSION® PLKO.1-puro Empty Vector Control Transduction Particles were used as a control for the transduction procedure.
+ Open protocol
+ Expand
2

Lentiviral-mediated Gene Silencing in Cell Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
Short-hairpin(sh) approach using lentiviral particles was used for studies to achieve the silencing of genes of interest. Silencing DIAPH1 and AGER in HiPSC-CMs and DIAPH1 in H9C2 and HMVECs was achieved using mission shRNA custom lentiviral particles from Millipore Sigma (Supplementary Table 8). Short-hairpin targeting scrambled (Scr) sequence was used as a control for studies. For all cell types, transduction was performed at a confluency of 30–40%. In total, 1.5 × 106 viral particles of either Scr or gene of interest at an approximate multiplicity of infection (MOI) of 3 were used for transduction. Hexadimethrine bromide (Sigma cat# 107689) at a concentration of 8 µg/ml was used to increase lentiviral uptake and transduction efficiency. Cells were incubated for 5–6 h with Lentiviral particles to obtain excellent transduction efficiency, and thereafter, cultures were replaced with regular growth medium. Forty-eight hours post transduction, cells were selected against puromycin resistance (Sigma cat# P8833) at a concentration of 2 ng/ml for successful transduction. In the case of HiPSC-CMs, due to poor transduction efficiency, precursor HiPSCs were initially transduced and tested for silencing efficiency by qPCR. Upon achieving successful transduction, the cells were differentiated into HiPSC-CMs for experiments.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!